- Home
- BFST vs QDEL Comparison
BFST vs QDEL Comparison
Compare BFST & QDEL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | BFST | QDEL |
|---|---|---|
| Founded | 2006 | 1979 |
| Country | United States | United States |
| Employees | 842 | N/A |
| Industry | Major Banks | Medical Specialities |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 877.1M | 1.0B |
| IPO Year | 2014 | 2022 |
Fundamental Metrics
Financial Performance| Metric | BFST | QDEL |
|---|---|---|
| Price | $27.79 | $11.83 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 4 | 4 |
| Target Price | ★ $32.75 | $28.25 |
| AVG Volume (30 Days) | 135.1K | ★ 2.3M |
| Earning Date | 04-27-2026 | 05-05-2026 |
| Dividend Yield | ★ 2.23% | N/A |
| EPS Growth | 23.45 | ★ 45.35 |
| EPS | ★ 0.68 | N/A |
| Revenue | $10,704,000.00 | ★ $2,730,200,000.00 |
| Revenue This Year | $22.71 | $3.51 |
| Revenue Next Year | $5.02 | $3.86 |
| P/E Ratio | $39.85 | ★ N/A |
| Revenue Growth | ★ 1.20 | N/A |
| 52 Week Low | $22.56 | $9.92 |
| 52 Week High | $30.32 | $35.58 |
Technical Indicators
Market Signals| Indicator | BFST | QDEL |
|---|---|---|
| Relative Strength Index (RSI) | 53.56 | 46.76 |
| Support Level | $26.78 | $10.86 |
| Resistance Level | $27.89 | $12.85 |
| Average True Range (ATR) | 0.53 | 0.91 |
| MACD | 0.00 | 0.26 |
| Stochastic Oscillator | 88.37 | 64.16 |
Price Performance
Historical ComparisonAbout BFST Business First Bancshares Inc.
Business First Bancshares Inc is a bank holding company. The company's services include personal and commercial banking, treasury management, and wealth solutions. It provides a range of financial services to small-to-midsized businesses and professionals. The company generates the majority of its revenues from interest income on loans, customer service and loan fees, and interest income from securities.
About QDEL QuidelOrtho Corporation
QuidelOrtho Corp is engaged in the development, manufacturing, and marketing of rapid diagnostic testing solutions. The company is engaged in immunoassay and molecular testing, clinical chemistry, and transfusion medicine, which helps clinicians and patients to make decisions across the globe. Geographically, the company has its presence in North America, EMEA, China, and Other countries. It generates the majority of its revenue from North America.